Thomas Jens Ettrich (Thomas J Ettrich, Thomas Ettrich)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

Cancers

Current oncology (Toronto, Ont.)

International journal of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer (2024)
Daniel Vogele, Teresa Mueller, Daniel Wolf, Stephanie Otto, Sabitha Manoj, Michael Götz, Thomas Jens Ettrich, Meinrad Beer
Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors. Diagnostics (Basel, Switzerland) 14 (2) (2024)
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer 154 (12) (2024)
Michael Masetti, Salah-Eddin Al-Batran, Thorsten O Goetze, Peter Thuss-Patience, Jorge Riera Knorrenschild, Eray Goekkurt, Gunnar Folprecht, Thomas Jens Ettrich, Udo Lindig, Kim Barbara Luley, Daniel Pink, Tobias Dechow, Disorn Sookthai, Sabine Junge, Maria Loose, Claudia Pauligk, Sylvie Lorenzen
Efficacy of ramucirumab combination chemotherapy as second-line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first-line therapy. International journal of cancer 154 (12) (2024)
Thomas Jens Ettrich, Dominik Paul Modest, Marianne Sinn, Jana K Striefler, Bernhard Opitz, Thorsten Goetze, Eike Gallmeier, Stefan Angermeier, Ludwig Fischer von Weikersthal, Lutz Jacobasch, Dirk Waldschmidt, Michael Niedermeier, Michael Sohm, Andreas W Berger, Giulia Manzini, Uli Fehrenbach, Timo Alexander Auer, Clarissa Hosse, Daniel Vogele, Disorn Sookthai, Marina Schaaf, Rainer Muche, Axel Hinke, Thomas Seufferlein, Lukas Perkhofer
Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Daniel Vogele, Teresa Mueller, Daniel Wolf, Stephanie Otto, Sabitha Manoj, Michael Götz, Thomas Jens Ettrich, Meinrad Beer
Applicability of the CT Radiomics of Skeletal Muscle and Machine Learning for the Detection of Sarcopenia and Prognostic Assessment of Disease Progression in Patients with Gastric and Esophageal Tumors. Diagnostics (Basel, Switzerland) 14 (2) (2024)
Sylvie Lorenzen, Thorsten Oliver Götze, Peter C Thuss-Patience, Matthias Biebl, Nils Homann, Michael Schenk, Udo Lindig, Vera Heuer, Albrecht Kretzschmar, Eray Goekkurt, Georg Martin Haag, Jorge Riera-Knorrenschild, Claus Bolling, Ralf-Dieter Hofheinz, Tianzuo Zhan, Stefan Angermeier, Thomas Jens Ettrich, Alexander Reinhard Siebenhüner, Moustafa Elshafei, Wolf Otto Bechstein, Timo Gaiser, Maria Loose, Disorn Sookthai, Christina Kopp, Claudia Pauligk, Salah-Eddin Al-Batran, null null
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Daniel Vogele, Stefan Andreas Schmidt, Daniel Gnutzmann, Wolfgang M Thaiss, Thomas Jens Ettrich, Marko Kornmann, Meinrad Beer, Markus S Juchems
Gastroenteropancreatic Neuroendocrine Tumors-Current Status and Advances in Diagnostic Imaging. Diagnostics (Basel, Switzerland) 13 (17) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Klara Dorman, Stefan Boeck, Robert J Snijder, Jens Thomas Siveke, Michael Schenk, Julia Mayerle, Karel Caca, Jens Freiberg-Richter, Ludwig Fischer von Weikersthal, Frank Kullmann, Anke Reinacher-Schick, Martin Fuchs, Stephan Kanzler, Volker Kunzmann, Thomas Jens Ettrich, Danmei Zhang, Swantje Held, Ayad Abdul-Ahad, Michael von Bergwelt-Baildon, Volker Heinemann, Michael Haas
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh ®TM ) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer. Current oncology (Toronto, Ont.) 30 (6) (2023)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Thomas Seufferlein, Julia Mayerle, Stefan Böck, Thomas Brunner, Thomas Jens Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Mr Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl
Zeitschrift fur Gastroenterologie 60 (6) (2022)
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, Christoph Springfeld, Thomas Jens Ettrich, Kersten Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Siegler, Matthias P A Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf Bechstein, Peter Reichardt, Hagen Flach, Timo Gaiser, Achim Battmann, Fuat S Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten O Göetze, Salah-Eddin Al-Batran
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Mareike Waldenmaier, Lucas Schulte, Jonathan Schönfelder, Axel Fürstberger, Johann M Kraus, Nora Daiss, Tanja Seibold, Mareen Morawe, Thomas Jens Ettrich, Hans Armin Kestler, Christoph Kahlert, Thomas Seufferlein, Tim Eiseler
Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients. Cancers 14 (4) (2022)
Thomas Seufferlein, Thomas Jens Ettrich, Stefan Menzler, Helmut Messmann, Gerhard Kleber, Alexander Zipprich, Stefanie Frank-Gleich, Hana Algül, Klaus Metter, Frank Odemar, Theodor Heuer, Ulrich Hügle, Rüdiger Behrens, Andreas W Berger, Catharina Scholl, Katharina L Schneider, Lukas Perkhofer, Friederike Rohlmann, Rainer Muche, Julia C Stingl
Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial. The American journal of gastroenterology 117 (6) (2022)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Niklas Sturm, Jasmin Selina Schuhbaur, Felix J Hüttner, Lukas Perkhofer, Thomas Jens Ettrich
Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions. Cancers 14 (22) (2022)
Thomas Seufferlein, Julia Mayerle, Stefan Böck, Thomas Brunner, Thomas Jens Ettrich, Lars Grenacher, Thomas Mathias Gress, Thilo Hackert, Volker Heinemann, Angelika Mr Kestler, Marianne Sinn, Andrea Tannapfel, Ulrich Wedding, Waldemar Uhl
Zeitschrift fur Gastroenterologie 60 (11) (2022)
Niklas Sturm, Thomas Jens Ettrich, Lukas Perkhofer
The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers 14 (1) (2022)
Thomas Jens Ettrich, Thomas Seufferlein
Systemic Therapy for Metastatic Pancreatic Cancer. Current treatment options in oncology 22 (11) (2021)
Alica K Beutel, Lena Schütte, Jeanette Scheible, Elodie Roger, Martin Müller, Lukas Perkhofer, Annika M T U Kestler, Johann M Kraus, Hans Armin Kestler, Thomas F E Barth, Johannes Lemke, Marko Kornmann, Thomas Jens Ettrich, Johann Gout, Thomas Seufferlein, Alexander Kleger
A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Cancers 13 (11) (2021)
Frank Arnold, Johann Gout, Heike Wiese, Stephanie E Weissinger, Elodie Roger, Lukas Perkhofer, Karolin Walter, Jeanette Scheible, Caterina Prelli Bozzo, André Lechel, Thomas Jens Ettrich, Ninel Azoitei, Li Hao, Axel Fürstberger, Ewa K Kaminska, Konstantin Maria Johannes Sparrer, Volker Rasche, Sebastian Wiese, Hans Armin Kestler, Peter Möller, Thomas Seufferlein, Pierre-Olivier Frappart, Alexander Kleger
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer. Cancer research 81 (7) (2021)
Thomas Jens Ettrich, Lukas Perkhofer, Thomas Decker, Ralf-Dieter Hofheinz, Volker Heinemann, Thomas Hoffmann, Holger F Hebart, Thomas Herrmann, Carla V Hannig, Petra Büchner-Steudel, Melanie Güthle, Patrick C Hermann, Andreas W Berger, Thomas Seufferlein
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111). International journal of cancer 148 (6) (2020)
Salah-Eddin Al-Batran, Ralf-Dieter Hofheinz, Alexander Reichart, Claudia Pauligk, Caroline Schönherr, Rudolf Schlag, Gabriele Siegler, Steffen Dörfel, Michael Koenigsmann, Mark-Oliver Zahn, Jörg Schubert, Ali Aldaoud, Heinz-Gert Höffkes, Holger Schulz, Lars Hahn, Jens Uhlig, Wolfgang Blau, Martina Stauch, Jörg Weniger, Martin Wolf, Lutz Jacobasch, Stephan Bildat, Jürgen Wehmeyer, Nils Homann, Jörg Trojan, Oliver Waidmann, Thomas Fietz, Hans-Peter Feustel, Matthias Groschek, Jan Wierecky, Karin Waibel, Stefan Mahlmann, Uwe Schwindel, Uwe Peters, Gunter Schuch, Daniel Pink, Henning Eschenburg, Marcus-A Wörns, Hans-Detlev Harich, Ludwig Fischer von Weikersthal, Klaus-Ulrich Däßler, Dirk M Behringer, Helmut Messmann, Albrecht Kretzschmar, Eike Gallmeier, Helmut Forstbauer, Volker Kunzmann, Jens Papke, Petra Büchner-Steudel, Ursula Vehling-Kaiser, Christoph Springfeld, Arndt Vogel, Thomas Jens Ettrich, Marina Schaaf, Gerrit Zur Hausen, Thorsten Oliver Götze, null null
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. International journal of cancer 148 (6) (2020)
Thomas Jens Ettrich, Andreas W Berger, Lukas Perkhofer, Severin Daum, Alexander König, Andreas Dickhut, Uwe Wittel, Kai Wille, Michael Geissler, Hana Algül, Eike Gallmeier, Jens Atzpodien, Marko Kornmann, Rainer Muche, Nicole Prasnikar, Andrea Tannapfel, Anke Reinacher-Schick, Waldemar Uhl, Thomas Seufferlein
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group. BMC cancer 18 (1) (2018)

Thomas Jens Ettrich.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas J Ettrich, Thomas Ettrich)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Jens Ettrich (Thomas J Ettrich, Thomas Ettrich)